A recent symposium exploring causes of mood disorders, novel treatments, and proposals for how to bring new drugs to market was held at the Icahn School of Medicine at Mount Sinai, supported by the Deborah Elkins Foundation. Wayne Goodman, MD, Chair of Psychiatry, noted, “The symposium is part of a broader initiative at Mount Sinai to influence and encourage basic discoveries in neuroscience, better understand the causes of major psychiatric disorders, and develop innovative treatments.” Dennis Charney, MD, Dean of the Icahn School of Medicine called for a revolution in the way mental illness is studied. “Identification of new molecular targets for drug development for psychiatric disorders has stalled, and we are still treating the symptoms of disease rather than the disease itself,” said Dr Charney. “We also need new psychosocial therapy paradigms, better ways to diagnose, new preventative measures for individuals at high risk for psychiatric disorders, and to break down the barriers to diagnosis and treatment in the community.” Learn more